NOVEL LACTOBACILLUS PLANTARUM PROBIO 88, EXTRACT THEREOF, AND COMPOSITION

WIPO Patent Application WO/2023/048334

A1

The present invention provides a Lactobacillus plantarum) Probio 88 strain and an extract and a composition, each containing same. The strain, extract, and composition according to the present invention have the effects of suppressing SARS-CoV-2 infection and replication, reducing the intracellular accumulation of inflammation and reactive oxygen species (ROS), decreasing extracellular signal-regulated kinase (ERK) activity, enhancing antiviral activity, and being able to be advantageously used as a therapeutic agent or adjuvant for coronaviral diseases.

JPH072762	[Title of the Invention] A method for dipping and crushing silo-stored corn using microbial inoculation.
WO/2023/229394	LACTOBACILLUS PARACASEI STRAIN OR LACTOBACILLUS PLANTARUM STRAIN DERIVED FROM HUMAN BODY, HAVING BODY FAT REDUCING ACTIVITY, AND MIXTURE COMPOSITION COMPRISING SAME
JP3732428	CULTURE MEDIUM FOR DETECTING VAN A TYPE AND VAN B TYPE VANCOMYCIN-RESISTANT ENTEROCOCCUS AND USE THEREOF

PARK YONG-HA (KR)
LEW LEE CHING (KR)
HOR YAN YAN (KR)

PCT/KR2021/017005

March 30, 2023

November 18, 2021

Click for automatic bibliography generation  

PROBIONIC INC (KR)

C12N1/20; A23K10/16; A23L33/135; A61K8/99; A61K35/742; A61P31/14; A61Q19/00; C12R1/25

KR20150044764A	2015-04-27
KR20200007742A	2020-01-22
KR20160047125A	2016-05-02
KR20180033912A	2018-04-04

RATHER IRFAN A., CHOI SY-BING, KAMLI MAJID RASOOL, HAKEEM KHALID REHMAN, SABIR JAMAL S. M., PARK YONG-HA, HOR YAN-YAN: "Potential Adjuvant Therapeutic Effect of Lactobacillus plantarum Probio-88 Postbiotics against SARS-COV-2", VACCINES, vol. 9, no. 10, pages 1067, XP093053525, DOI: 10.3390/vaccines9101067

KIM, Youngrok (KR)

View/Download PDF      PDF Help

Previous Patent: TWO-FLUID SYRINGE MODULE FACILITATING MIXING

Next Patent: COSMETIC CONTAINER HAVING CLOSED STRUCTURE